Prospectus Exposure - Cengild Medical Berhad
The prospectuses published here have not been registered with the SC under Section 232 of the Capital Markets and Services Act 2007 and is solely for the purpose of seeking comments from the public. THESE PROSPECTUSES SHOULD NOT BE USED FOR MAKING ANY INVESTMENT DECISION. Securities cannot be offered and application for securities cannot be accepted until the prospectus has been registered by the SC.
The SC shall not be liable for any non-disclosure on the part of the corporation and takes no responsibility for the contents of the prospectuses, makes no representation as to its accuracy or completeness and expressly disclaims any liability for any loss suffered arising from or in reliance upon the whole or any part of the contents of the prospectuses published here.
Details of prospectus
Company Name : Cengild Medical Berhad (“Cengild Medical”)
Proposal Type and Board : Initial Public Offering (“IPO”) on the ACE Market
Principal Adviser(s) : Hong Leong Investment Bank Berhad
Principal Activity :

Cengild Medical is an investment holding company, while its subsidiary is a healthcare service provider operating a medical centre specialising in the diagnosis and treatment of gastrointestinal and liver diseases, and obesity.

Shares to be issued/offered :

IPO of 218,800,000 new ordinary shares in Cengild Medical (“IPO Shares”) in conjunction with the listing of and quotation for the entire enlarged issued share capital of Cengild Medical comprising 818,800,000 shares on the ACE Market of Bursa Malaysia Securities Berhad involving:

  1. Institutional offering of 162,860,000 IPO Shares to institutional and selected investors at the institutional price to be determined by way of bookbuilding ("Institutional Price"); and
  2. Retail offering of 55,940,000 IPO Shares to the Malaysian public, the eligible directors, eligible key senior management, eligible employees and persons who have contributed to the success of Cengild Medical and its subsidiary at the retail price ("Retail Price"), payable in full upon application and subject to refund of the difference between the Retail Price and the Final Retail Price (as defined in this prospectus) in the event that the Final Retail Price is less than the Retail Price,

subject to the clawback and reallocation provisions. The Final Retail Price will be equal to the lower of:

  1. the Retail Price; or
  2. the Institutional Price.
Date of Exposure : 11 August 2021
Download prospectus in separate files
  • Cover
  • Indicative Timetable
  • Table of Contents
  • Presentation of Financial and Other Information
  • Forward-Looking Statements
  • Definitions
  • Glossary of Technical Terms
(pdf - 689KB)
Corporate Directory (pdf - 121KB)
Prospectus Summary (pdf - 460KB)
Details of Our IPO (pdf - 390KB)
Information on Promoters, Substantial Shareholders, Directors and Key Senior Management (pdf - 566KB)
Information on Our Group (pdf - 462KB)
Business Overview (pdf - 366KB)
Independent Market Research Report (pdf - 1.71MB)
Risk Factors (pdf - 235KB)
Related Party Transactions (pdf - 255KB)
Conflict of Interest (pdf - 258KB)
Financial Information (pdf - 739KB)
Accountants' Report (pdf - 5.13MB)
Reporting Accountants' Report on Pro Forma Consolidated Financial Information (pdf - 968KB)
Additional Information (pdf - 115KB)
Summarised Procedures for Application and Acceptance (pdf - 244KB)
Appendix A: By-Laws for the LTIP (pdf - 310KB)


General Line: +603-6204 8000
related sites
© Copyright Securities Commission Malaysia   |   Contact Us   |  Disclaimer  |  The site is best viewed using Internet Explorer 11 and Google Chrome with mimimum resolution of 1280x1024
Generic Popup